I reported previously (May 2015) on the pain measurement device developed by Israel’s Medasense Biometrics.  The innovative PMD200 has now received CE approval, allowing physicians to assess and manage pain for patients who cannot communicate.

http://www.medasense.com/medasense-launches-new-pain-monitoring-device-pmd200-following-european-ce-approval/